Stay updated on Ramucirumab vs Placebo in HCC Clinical Trial

Sign up to get notified when there's something new on the Ramucirumab vs Placebo in HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ramucirumab vs Placebo in HCC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3. This change updates the site version tag and does not affect study content.
    Difference
    0.0%
    Check dated 2026-03-06T15:48:47.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is shown in the page footer, replacing v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-12T20:32:11.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T12:16:59.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Added a glossary toggle and updated labels with capitalization for QC and FEAR Act fields, plus Revision: v3.4.0. These are cosmetic/documentation updates.
    Difference
    0.1%
    Check dated 2026-01-29T06:26:09.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.3.3 to v3.3.4. This is a minor metadata update that does not affect study content, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:31:47.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added a consolidated Locations section with state site listings (California, District of Columbia, Iowa, Massachusetts, New York, Oklahoma, Oregon) and updated the page revision to v3.3.3; removed the HHS Vulnerability Disclosure link.
    Difference
    0.4%
    Check dated 2025-12-23T10:22:55.000Z thumbnail image

Stay in the know with updates to Ramucirumab vs Placebo in HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ramucirumab vs Placebo in HCC Clinical Trial page.